
Kirsten Falk, Pioneer of MHC Peptides, Dies at 61
Kirsten Falk, Ph.D., passed away on December 18, 2024. Her early work was a monumental step in identifying how peptides bind to MHC molecules.
Kirsten Falk, Ph.D., passed away on December 18, 2024. Her early work was a monumental step in identifying how peptides bind to MHC molecules.
Leslie Berg, Ph. D., speaks to AAI about receiving the 2025 AAI Lifetime Achievement Award for her contributions to the field and service to AAI.
Sachin Bhagchandani, postdoctoral fellow at the Yale School of Medicine, talks to AAI about his career so far and his passion for immunology.
Dr. Sarah Sletten, Associate Professor at the University of North Dakota School of Medicine and Health Sciences, talks about her research and the AAI Annual Meeting.
Jen Gommerman, Ph.D., of the University of Toronto, answers our questions about being included in the DFAAI Class of 2025.
Subhash Arya is a post-doctoral fellow at the University of Michigan, Ann Arbor. Arya’s fascination with neutrophils drives his current…
AAI members Gordon J. Freeman, Ph.D. (AAI ’01) and Arlene Helen Sharpe, M.D., Ph.D. (AAI ’96, president 2016–17) received the 2024 David and Beatrix…
Margaret S. Bynoe, Ph.D., passed away on Thursday, November 28, 2024. She was a neuroimmunologist who made important breakthroughs in…
Loretta Doan, CEO of AAI, shares some of the AAI achievements that have advanced the vision of our strategic framework in 2024.
AAI member, Deepta Bhattacharya, talks to us about the new Center for Advanced Molecular and Immunological Therapies (CAMI) at the University of Arizona.